What Is the Disease of Kings? The History of Gout

Gout earned its nickname “the disease of kings” because the foods and drinks that trigger it were, for most of human history, luxuries only the wealthy could afford. The name derives from the Latin word gutta, meaning “drop,” reflecting the medieval belief that an excess of bodily fluid literally dropped into a joint and caused searing pain.1PubMed Central. A concise history of gout and hyperuricemia and their treatment Rich meat, shellfish, and copious wine were the hallmarks of royal banquets and aristocratic tables, and the men who indulged in them were disproportionately the ones hobbled by swollen, agonizing joints. But the story of gout stretches back thousands of years before that label stuck, and the science behind it turns out to be far more interesting than a simple tale of overindulgence.

From Ancient Egypt to Galen

Gout is one of the oldest recognized diseases in Western medicine. Egyptian physicians described a painful condition of the big toe as early as 2640 BCE, making it among the first joint diseases ever documented. By the fifth century BCE, Hippocratic writers had catalogued its clinical features, noting that it struck men far more often than women and typically appeared after puberty in men but not until after menopause in women. That observation, made roughly 2,400 years ago, holds up remarkably well against modern epidemiological data.

The physician Galen, working in Rome in the second century CE, pushed the understanding considerably further. He described gout as a disease caused by fluid overflow that infiltrated nerves and joints, producing pain. In his view, the offending fluid could be blood, phlegm, or a mixture of bile and blood, and the thick, mucous residue that accumulated in joints was what we now call tophi, the chalky deposits of urate crystals visible under the skin.2PubMed. Gout From the Corpus Hippocraticum to the Renaissance: The Role of Galen Galen’s framework was wrong about the specific fluids involved, but his clinical descriptions of the disease’s course, its relationship to diet, and the formation of hard deposits in joints were strikingly accurate for someone working without a microscope or any knowledge of chemistry.

Why the Big Toe Gets Hit First

One of gout’s most distinctive features is its fondness for the joint at the base of the big toe, a presentation so characteristic it has its own Latin name: podagra. About half of all first gout attacks strike there. The reason is not random. Uric acid crystals form more readily in cooler environments, at lower pH, and in joints exposed to repeated minor physical stress. The foot checks every box. It is the coolest part of the body, it absorbs impact with every step, and the first toe joint is especially prone to osteoarthritis, which changes the local tissue environment in ways that encourage crystal formation.3PubMed Central. Revisiting the pathogenesis of podagra: why does gout target the foot? Ancient physicians noticed this pattern without understanding its cause. They just knew that when a wealthy Roman or a medieval duke woke up screaming in the night, it was almost always the foot.

Kings, Aristocrats, and Lead-Sweetened Wine

The roster of historical gout sufferers reads like a who’s who of European power. Henry VIII, whose enormous appetite and expanding waistline are practically synonymous with Tudor England, was famously incapacitated by gout in his later years. Benjamin Franklin, another well-known sufferer, wrote satirical essays about the disease while enduring attacks so severe he could barely walk. Charles V of Spain, Alexander the Great (by some accounts), and numerous popes all dealt with gouty joints.

But the connection between gout and ruling classes was not purely about rich food. Among Roman aristocrats, there may have been an additional culprit: lead. Romans used lead-lined vessels to prepare and store a grape syrup called sapa, which was used to sweeten wine. Chronic low-level lead exposure impairs the kidneys’ ability to excrete uric acid, producing what physicians later termed “saturnine gout” (after Saturn, the alchemical symbol for lead).4PubMed. Saturnine gout among Roman aristocrats. Did lead poisoning contribute to the fall of the Empire? The aristocrats who could afford the finest lead-sweetened wines were the same ones developing gout at high rates, which may have reinforced the perception that the disease was a mark of privilege rather than a sign of poisoning.

This pattern repeated in eighteenth-century England, where cheap port wine was often adulterated with lead to improve its taste. The epidemic of gout among Georgian-era gentlemen was very likely amplified by the same mechanism Roman elites had unwittingly suffered. Lead was not the sole cause, but it was an accelerant that compounded the dietary risks.

The Medici and the Paleopathological Record

Studying gout in historical figures has moved well beyond written accounts. When researchers examined the skeletal remains of the Medici family of Florence, they found that the famous “gout of the Medici” was actually a mix of several joint conditions. Diffuse skeletal hyperostosis and rheumatoid arthritis accounted for some of the family’s joint problems, but true uric acid gout was confirmed in Grand Duke Ferdinand I, who ruled Tuscany from 1587 to 1609, and in Anton Francesco Maria, a probable illegitimate member of the family who lived in the mid-seventeenth century.5PubMed. On the history of gout: paleopathological evidence from the Medici family of Florence The finding is a useful reminder that historical labels can be imprecise. When chroniclers of the era wrote that a noble was suffering from “gout,” they sometimes meant any severe joint pain, not the specific crystal-driven disease we recognize today.

An Evolutionary Peculiarity

Gout exists in humans partly because of a genetic quirk we share with other great apes. Most mammals produce an enzyme called uricase that breaks down uric acid into a more soluble compound that the kidneys easily flush out. Humans, chimpanzees, gorillas, and orangutans all lost the functional gene for this enzyme millions of years ago.6PubMed. Regulation of uric acid metabolism and excretion Without uricase, uric acid accumulates in the blood at concentrations several times higher than in most other animals. Research on the molecular timeline suggests this loss occurred in stages across different primate lineages, with the inactivation in gibbons happening relatively recently, around 10 to 15 million years ago, late enough that some gibbon species might still carry a functional copy of the gene.7Molecular Biology and Evolution. Loss of Urate Oxidase Activity in Hominoids and its Evolutionary Implications

Why would evolution allow this seemingly harmful change to persist? One leading hypothesis is that uric acid acts as a powerful antioxidant in the bloodstream, and at a time when our ancestors were losing the ability to synthesize vitamin C (another antioxidant), having higher circulating uric acid may have offered a survival advantage.8PubMed. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity The trade-off is that we live with uric acid levels perpetually close to the saturation point. It does not take much of a push from diet, genetics, or kidney function to tip the balance toward crystal formation and gout.

How a Gout Attack Actually Happens

The biochemistry starts with purines, compounds found in every cell of the body and in many foods. When purines break down, the final step in humans produces uric acid. The enzyme responsible for this last conversion, xanthine oxidase, catalyzes the oxidation of precursor molecules into uric acid.9PubMed. Hesperetin acts as a potent xanthine oxidase inhibitor: New evidence from its reactive oxygen suppression and enzyme binding Under normal circumstances, the kidneys handle about two-thirds of uric acid excretion, with the gut managing the rest. When the kidneys fall behind or the body produces too much, blood uric acid rises. Once it exceeds the saturation threshold, needle-shaped monosodium urate crystals can form in and around joints.

The crystals themselves do not cause pain directly. The agony of a gout attack is an immune overreaction. When immune cells encounter the crystals, they activate an inflammatory alarm system called the NLRP3 inflammasome, which triggers the release of the signaling molecule IL-1β. This sets off an intense local inflammatory cascade with redness, heat, swelling, and the kind of pain that patients describe as feeling like a joint is on fire.10PubMed Central. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout The immune system is essentially treating the crystals as a foreign invader, mounting a full-scale attack against something the body itself produced.

On the kidney side, the balance of uric acid excretion depends heavily on specialized transporter proteins in the kidney’s proximal tubule. One called URAT1 is the main player in reabsorbing uric acid from urine back into the blood. When URAT1 is overactive or when the kidney’s filtering capacity declines, uric acid builds up.11PubMed Central. URAT1 inhibition in hyperuricemia and gout: from transporter biology to clinical precision therapy This is why kidney disease and gout so often travel together, and why many gout medications work by targeting these transporters to increase uric acid excretion.

Diet, Alcohol, and What the Evidence Actually Shows

The “disease of kings” label stuck because of the dietary connection, but modern research has refined the picture considerably. A large meta-analysis pooling data from multiple studies found that alcohol carried the strongest dietary association with gout risk, roughly two and a half times greater odds of developing gout among heavy drinkers compared to non-drinkers. Fructose, the sugar abundant in sweetened beverages and fruit juice, came in second at about double the risk. Red meat and seafood each raised risk by about 30 percent.12PubMed. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review

The protective side of the equation is just as informative. Dairy products cut gout risk roughly in half, and coffee showed a similarly strong protective association. Soy foods offered a modest benefit. And here is the surprise that contradicts centuries of dietary advice: purine-rich vegetables like spinach, asparagus, and mushrooms showed no increase in gout risk, and in some analyses appeared slightly protective.12PubMed. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review For generations, gout patients were told to avoid all high-purine foods indiscriminately. The evidence suggests the type of purine source matters enormously: animal-derived purines raise risk, while plant-derived purines do not.

A large prospective study following tens of thousands of men reached similar conclusions: those eating the most meat had about 40 percent higher gout risk than those eating the least, and seafood raised it by about 50 percent. Meanwhile, men who consumed the most dairy had nearly half the gout risk of those consuming the least.13PubMed. Purine-rich foods, dairy and protein intake, and the risk of gout in men The mechanism behind dairy’s protection is still debated, but the proteins in milk appear to increase uric acid excretion through the kidneys.

Fructose deserves special attention because it explains why gout has surged in modern populations where nobody is feasting at royal banquets. When the body metabolizes fructose, it rapidly depletes cellular energy stores in a way that accelerates purine breakdown and uric acid production. The rise of high-fructose corn syrup in processed foods and soft drinks since the 1970s tracks closely with rising gout rates across all income levels, effectively democratizing a disease that was once confined to the elite.

Why Women Are Protected Until Menopause

Gout has always been overwhelmingly a male disease. In the Hippocratic writings, the observation that women rarely developed gout before menopause was already well established. Modern epidemiology confirms it: gout is roughly three to four times more common in men than in women, but the gap narrows sharply after menopause. The explanation centers on estrogen, which promotes more efficient kidney excretion of uric acid. Women maintain lower uric acid levels throughout their reproductive years, essentially staying farther from the crystallization threshold. After menopause, when estrogen levels fall, uric acid rises toward male-range levels and gout risk climbs.14PubMed Central. Menopause, Postmenopausal Hormone Use and Risk of Incident Gout This is one reason gout in women tends to appear later in life and is sometimes initially misdiagnosed as osteoarthritis or rheumatoid arthritis.

The Chemical Breakthrough That Proved What Gout Really Is

For centuries, gout was understood through the lens of humoral theory. The decisive scientific breakthrough came in 1848, when the English physician Alfred Baring Garrod developed a simple “thread test” that demonstrated excess uric acid in the blood of gout patients. By placing a linen thread in acidified blood serum and observing uric acid crystals depositing on it, Garrod showed that gout was fundamentally a chemical disease. He proposed that the kidneys in gout patients had a reduced ability to excrete uric acid, a conclusion that remains central to our understanding.15JAMA Network. THE PATHOGENESIS OF GOUT This was a landmark moment in medicine: a disease that had been attributed to divine punishment, moral failure, or imbalanced humors was suddenly, provably, a matter of chemistry.

From Colchicine to Engineered Enzymes

The treatment history of gout is one of the longer pharmacological stories in medicine. Colchicine, an alkaloid extracted from the autumn crocus, was used as a powerful purgative in ancient Greece. Its first targeted use against gout specifically is credited to the Byzantine physician Alexander of Tralles in the sixth century.16International journal of health sciences. updated review on gout Colchicine remains in clinical use today, which makes it one of the oldest continuously used drugs in the world. It works not by lowering uric acid but by dampening the inflammatory response to crystals, essentially calming the immune system’s overreaction.

The mid-twentieth century brought allopurinol, a drug that blocks xanthine oxidase, the enzyme that produces uric acid in the first place. Allopurinol became the backbone of long-term gout management and remains the most commonly prescribed urate-lowering therapy worldwide.17PubMed Central. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol Newer drugs targeting the same enzyme, like febuxostat, and uricosuric agents that increase kidney excretion of uric acid by blocking the URAT1 transporter have expanded the options.18PubMed Central. Urate Transporters in the Kidney: What Clinicians Need to Know

For patients with severe, treatment-resistant gout, the most dramatic modern option is pegloticase, an engineered version of the very enzyme humans lost millions of years ago. It converts uric acid into the easily excreted compound allantoin, essentially doing what our broken uricase gene can no longer do. In two randomized trials, about 42 percent of patients receiving pegloticase every two weeks achieved sustained lowering of uric acid to target levels, compared to zero in the placebo group. Among those with visible tophi, 40 percent saw at least one tophus completely resolve.19JAMA. Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment: Two Randomized Controlled Trials The fact that we can now pharmacologically replace a gene lost in the Miocene is one of the stranger full-circle moments in the history of this disease.

Gout as a Metabolic Warning Sign

The old view of gout as a standalone joint disease has given way to a more alarming picture. Gout and high uric acid levels are tightly woven into the cluster of conditions known as metabolic syndrome. People with metabolic syndrome have uric acid levels averaging about 8 percent higher than those without it.20Scientific Reports. Association between metabolic syndrome and uric acid: a systematic review and meta-analysis And the relationship appears to run in both directions: high uric acid does not just accompany obesity, high blood pressure, and insulin resistance, it may actively promote them. Evidence from both human studies and animal models suggests that elevated uric acid drives inflammation, contributes to fat accumulation, disrupts glucose regulation, and damages blood vessels.21PubMed. Gout and Metabolic Syndrome: a Tangled Web

Mendelian randomization analyses, which use genetic variants as natural experiments to test cause and effect, have found evidence that uric acid itself causally contributes to cardiovascular disease, chronic kidney disease, and diabetes.22PubMed Central. Exploration of the Interrelationship Between Serum Uric Acid, Gout, and Cardiac, Renal, and Metabolic Conditions in Middle Aged and Older People This reframes gout from an inconvenient joint problem into a potential early warning of systemic metabolic dysfunction. A first gout attack in a middle-aged person is worth taking seriously not just for joint health but as a signal to evaluate heart and kidney risk factors as well.

A Disease That Outlived Its Reputation

The “disease of kings” label has always carried a whiff of moral judgment, as though gout were a punishment for gluttony. That framing did real harm. For centuries it discouraged sympathy for sufferers and delayed serious scientific investigation, since the cure seemed obvious: just eat less. The reality, as Garrod’s thread test first hinted and modern genetics has confirmed, is that individual susceptibility varies enormously based on kidney transporter efficiency, enzyme activity, and hormonal status. Two people eating identical diets can have wildly different uric acid levels. Today, gout is the most common form of inflammatory arthritis in the developed world, affecting people across every income bracket, and its prevalence continues to rise in lockstep with obesity and fructose consumption. The kings have been dethroned, but their disease is everywhere.